Endoscopic sinus surgery, aspirin therapy effective for AERD management

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-01-29 03:30 GMT | Update On 2022-01-29 03:31 GMT

USA: Endoscopic sinus surgery (ESS) coupled with aspirin therapy may help in long-term management of AERD in majority of patients, which rarely requires the T2 biologics incorporation, finds a recent study. Further, patient questionnaires such as outcomes measure test score may help in the identification of aspirin therapy failure and guide the practitioner in making a decision on when to introduce T2 biologics into the patient's treatment regimen.

The findings of the study are published in the journal Allergy and Asthma Proceedings.

Type 2 (T2) biologics and/or aspirin therapy are used for the management of aspirin-exacerbated respiratory disease (AERD). Auddie M. Sweis, Pritzker School of Medicine, Evanston, Illinois, and colleagues aimed to identify the number of patients with AERD who tolerated aspirin therapy, yet due to persistent symptoms, incorporated T2 biologic management.

For the purpose, the researchers performed a retrospective review between July 2016 and June 2019. It included patients with AERD and who underwent ESS, aspirin desensitization (AD), and at least 6 months of aspirin therapy (ATAD) after AD, and who remained biologic-naive up through this timepoint. A total of 103 patients met inclusion criteria.

The primary outcome was introduction of a T2 biologic while on ATAD.

Key findings of the study include:

Two patients (1.9%) ultimately supplemented ATAD with a T2 biologic.
The mean outcomes measure test score after 6 months of ATAD for patients who received biologics was 40.5 versus 15 in those who did not receive biologics.
The mean differences between the postoperative predesensitization test score and the 6-month postdesensitization test score for patients who went on to receive biologics was an increase of 13 versus a decrease of 10 for those patients who did not receive biologics.

"ESS, coupled with AD and ATAD, was successful in the long-term management of the majority of the patients with AERD, which rarely required the incorporation of T2 biologics," wrote the authors.

"Patient questionnaires, such as outcomes measure test score, may identify aspirin therapy failures and help guide the practitioner in deciding when to introduce T2 biologics into the patient's treatment regimen."

Reference:

The study titled, "Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease," is published in the journal Allergy and Asthma Proceedings.

DOI: https://www.ingentaconnect.com/content/ocean/aap/2021/00000042/00000002/art00008

Article Source : Allergy and Asthma Proceedings

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Endoscopic sinus surgery, aspirin therapy effective for AERD management

Similar News

Asthma Tied to Higher Risk of Heart Valve Disease, BMJ Study Finds

Emphysema in smokers associated with low bone mineral density and higher fracture risk: Study

WHO Calls for Inclusion of Pregnant and Lactating Women in TB Research, vaccine trials

WHO Leads Global Call to Include Pregnant, Lactating Women in TB Research

Inhaled Molgramostim Promising for Autoimmune Pulmonary Alveolar Proteinosis: Phase 3 Trial Shows

Pimavanserin–Atomoxetine Combo Shows Promise in OSA: Study

Metformin Improves Lung Function and Symptom Control in Asthma Patients with Metabolic Syndrome: Study

Breaking a sweat: Using chloride in sweat to help diagnose cystic fibrosis